Add BrightSurf on Google Email

Massachusetts General Hospital


Combination treatment may improve survival of breast cancer patients with brain metastases

A combination of an anti-HER2 drug and an angiogenesis inhibitor significantly improves survival in a mouse model of brain metastatic breast cancer. The treatment extends patient survival by slowing the growth of brain tumors, making it a promising approach for patients with HER2-positive breast cancer who develop brain metastases.

SourceMassachusetts General Hospital·JournalProceedings of the National Academy of Sciences·DateNov 1, 2012

Taming physical forces that block cancer treatment

Researchers at MGH have identified components responsible for therapy-blocking solid stress and suggest therapeutic strategies. By measuring solid stress in tumor tissues, they found that inhibition of fibroblast growth can reduce solid stress and open up compressed blood vessels, improving treatment outcomes.

SourceMassachusetts General Hospital·JournalProceedings of the National Academy of Sciences·DateSep 20, 2012

CT angiography speeds emergency diagnosis of heart disease in low-risk patients

A study found that incorporating CT angiography into the initial evaluation of low-risk patients with chest pain reduced hospital stay time by half and decreased costs without increasing the risk of missed diagnosis. The use of CCTA also led to fewer adverse clinical events, but future studies are needed to confirm its effectiveness.

SourceMassachusetts General Hospital·JournalNew England Journal of Medicine·DateJul 25, 2012

Big advance against cystic fibrosis

Researchers at Massachusetts General Hospital have created human lung surface tissue in a dish, containing the delta-508 and G551D mutations responsible for most CF cases. This breakthrough enables drug screening on genuine human cells, paving the way for a potential therapy to control cystic fibrosis.

SourceMassachusetts General Hospital·JournalCell Stem Cell·DateApr 5, 2012